International Registry for Men With Advanced Prostate Cancer (IRONMAN)
NCT03151629
This study is recruiting at 35 US sites in 19 states, according to its ClinicalTrials.gov record last updated .
Summary
Our intent is to establish the International Registry to Improve Outcomes in Men with Advanced Prostate Cancer (IRONMAN) as a prospective, international cohort of minimum 5,000 men with advanced cancer, including men with mHSPC and M0/M1 CRPC. The goal is to establish a population-based registry and recruit patients across academic and community practices from Australia, Barbados, Brazil, Canada, Ireland, Jamaica, Kenya, Nigeria, Norway, Spain, South Africa, Sweden, Switzerland, the United Kingdom (UK), and the United States (US).
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- Prostate Cancer
Eligibility basics and study details
- Study type
- Observational
- Phase
- Not applicable
- Ages
- 21 years and older
- Sex
- Male
- Healthy volunteers
- Not accepted
- Sponsor
- Prostate Cancer Clinical Trials Consortium
- Last updated on ClinicalTrials.gov
- May 22, 2026
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
Alabama · 1
- University of Alabama- Tuscaloosa · Tuscaloosa, AL
California · 1
- University of California San Diego · San Diego, CA
Connecticut · 1
- Yale University · New Haven, CT
Florida · 2
- Mayo Clinic Jacksonville · Jacksonville, FL
- Moffitt Cancer Center · Tampa, FL
Georgia · 2
- Emory Winship Cancer Institute · Atlanta, GA
- Morehouse School of Medicine · Atlanta, GA
Illinois · 6
- Robert H. Lurie Comprehensive Cancer Center of Northwestern University · Chicago, IL
- University of Chicago · Chicago, IL
- University of Illinois at Chicago · Chicago, IL
- Kishwaukee Cancer Center · DeKalb, IL
- Delnor Cancer Center · Geneva, IL
- Warrenville Cancer Center · Warrenville, IL
Maryland · 1
- Johns Hopkins Sidney Kimmel Comprehensive Cancer Center · Baltimore, MD
Massachusetts · 2
- Dana-Farber Cancer Institute · Boston, MA
- University of Massachusetts Memorial Medical Center · Worcester, MA
Michigan · 1
- Karmanos Cancer Institute · Detroit, MI
Mississippi · 1
- University of Mississippi Medical Center · Jackson, MS
New York · 4
- NewYork-Presbyterian Brooklyn Methodist Hospital · Brooklyn, NY
- Columbia University Medical Center · New York, NY
- Memorial Sloan Kettering Cancer Center · New York, NY
- Weill Cornell Medical Center · New York, NY
North Carolina · 4
- University of North Carolina at Chapel Hill · Chapel Hill, NC
- Duke Cancer Network · Durham, NC
- Duke University · Durham, NC
- Durham VA Medical Center · Durham, NC
Ohio · 1
- University Hospitals Cleveland Medical Center · Cleveland, OH
Oregon · 1
- Oregon Health & Science University Hospital · Portland, OR
Pennsylvania · 2
- Fox Chase Cancer Center - Temple Health · Philadelphia, PA
- Reading Health System · West Reading, PA
South Carolina · 1
- Ralph H. Johnson VA Medical Center · Charleston, SC
Tennessee · 2
- Baptist Clinical Research Institute · Memphis, TN
- Memphis VA Medical Center · Memphis, TN
Virginia · 1
- University of Virginia · Charlottesville, VA
Wisconsin · 1
- University of Wisconsin Carbone Cancer Center · Madison, WI
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.